GSTO1-IN-6 is an allosteric and covalent GSTO1 inhibitor with an IC 50 of 457 nM. GSTO1-IN-6 markedly reduces Lipopolysaccharides (LPS) ( HY-D1056 )-induced IL-1β (IC 50 of 1.9 μM) and IL-18 (IC 50 of 10. μM) secretion in human monocyte-derived macrophages. GSTO1-IN-6 covalently modifies GSTO1-Cys32, inducing conformational changes and protein destabilization. GSTO1-IN-6 can be used for the research of inflammatory diseases.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Glutathione S-transferase | Products > Signaling Pathways > Interleukin Related
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。